DrugPatentWatch Database Preview
CEFOTAXIME SODIUM Drug Profile
» See Plans and Pricing
When do Cefotaxime Sodium patents expire, and when can generic versions of Cefotaxime Sodium launch?
Cefotaxime Sodium is a drug marketed by Aurobindo Pharma, Aurobindo Pharma Ltd, Cephazone Pharma, Hospira Inc, Lupin, and Wockhardt. and is included in nine NDAs.
The generic ingredient in CEFOTAXIME SODIUM is cefotaxime sodium. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cefotaxime sodium profile page.
Summary for CEFOTAXIME SODIUM
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 9 |
| Bulk Api Vendors: | 103 |
| Clinical Trials: | 7 |
| Patent Applications: | 915 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CEFOTAXIME SODIUM at DailyMed |
Recent Clinical Trials for CEFOTAXIME SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fayoum University Hospital | Phase 4 |
| Federal University of São Paulo | Phase 4 |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Medical Subject Heading (MeSH) Categories for CEFOTAXIME SODIUM
US Patents and Regulatory Information for CEFOTAXIME SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065517-002 | Nov 6, 2009 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Wockhardt | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065197-002 | Jun 20, 2008 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Hospira Inc | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065293-001 | Aug 10, 2006 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Aurobindo Pharma Ltd | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065516-001 | Nov 6, 2009 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Hospira Inc | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065292-001 | Aug 10, 2006 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Hospira Inc | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 203132-001 | Feb 19, 2016 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Lupin | CEFOTAXIME SODIUM | cefotaxime sodium | INJECTABLE;INJECTION | 065124-001 | Sep 24, 2003 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
